Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-08
2008-01-08
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S303000
Reexamination Certificate
active
10307678
ABSTRACT:
The present invention relates to insulin derivatives having a built-in glucose sensor and a polyol moiety, capable to deliver insulin from an injected depot of an insulin derivative according to the invention as a function of the glucose concentration in the surrounding tissue.
REFERENCES:
patent: 5478575 (1995-12-01), Miyazaki et al.
patent: 2002/0002876 (2002-01-01), Bezet
patent: 0424168 (1990-10-01), None
patent: WO 83/04255 (1983-12-01), None
patent: WO 84/01896 (1984-05-01), None
patent: WO 99/21888 (1999-05-01), None
patent: WO 00/64940 (2000-11-01), None
patent: WO 01/92334 (2001-12-01), None
Rudinger. In: Peptide Hormonse, JA Parsons, Ed. 1976, pp. 1-7 and A0.
SIGMA. Designing Custom Peptides. http://www.sigma-genosys.com/peptide—design.asp (Accessed Dec. 16, 2004). 2 pages.
Berendsen. A Glimpse of the Holy Grail? Science. 1998. 282. pp. 642-643.
Voet et al. Biochemistry, 2nd Edition. 1995, pp. 2 covers and 235-241.
Smilek et al. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA (1991) 88. pp. 9633-9637.
Abstract of Japanese Patent JP 2000 086534.
Abstract of Japanese Patent JP 04124144.
Abstract of Japanese Patent JP 04124145.
Brange. Galenics of Insulin. Springer-Verlag. pp. 20-27.
UK Prospective Diabetes Study Group. The Lancet. vol. 352. pp. 854-865 (1998).
Diabetes Control and Complications Trial Research Group, The New England Journal of Medicine. vol. 329. No. 14. pp. 977-987 (1993).
Eggert et al., J. Org. Chem., vol. 64, pp. 3846-3852 (1999).
Havelund Svend
Hoeg-Jensen Thomas
Markussen Jan
Cordero Garcia Marcela M
Novo Nordisk A S
Tsang Cecilia J.
Wilk-Orescan Rosemarie R.
LandOfFree
Glucose-dependent insulins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucose-dependent insulins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucose-dependent insulins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3940132